pharmaphorum

FEBRUARY 21, 2022

Already making inroads as a treatment for HER2-positive breast cancer, AstraZeneca and Daiichi Sankyo’s Enhertu has now shown efficacy in tumours that express lower levels of HER2 – potentially making it an option for a much broader group of patients. It’s a key moment for the two companies, as expansion into HER2-low breast cancer has been held up as a key requirement for Enhertu (trastuzumab deruxtecan) if it is to achieve its multibillion-dollar sales expectations.

Chemotherapy 132

Chemotherapy Labelling 132

Fierce Healthcare

FEBRUARY 1, 2022

Kindbody hits unicorn status with Vios Fertility Institute acquisition, new leadership additions. rtorrence. Tue, 02/01/2022 - 17:13.

129

129

Outsourcing Pharma

FEBRUARY 3, 2022

A leader from the artificial intelligence insights specialist talks discusses how the effective use of advanced analytics can lead to a number of benefits.

114

114

Fossil Remedies

FEBRUARY 18, 2022

PCD Pharma Franchise Business. Why are more aspirants willing to make a career in the field of pharmaceuticals? It is because the business is not only promising, but it is going to remain profitable for many years. People have become health conscious and they want to maintain fitness. Also, the recent Covid-19 outbreak has also changed the scenario.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Marketing Network

FEBRUARY 10, 2022

Experts from top life sciences companies discussed strategies for more effectively engaging oncologists at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about engaging oncologists in 2022: 1. Lead with clinical education. It’s no longer enough to build brand awareness, according to the panelists.

Communication 98

Communication 98

Fuld

FEBRUARY 28, 2022

Competitive Intelligence [CI] has gone through an evolution since becoming a corporate function nearly 4 decades ago. Once viewed as a niche area handled by somebody with the background of a CIA operative, we have seen tremendous growth in businesses adopting and implementing best practices to change how work is done and how intelligence is applied to business issues.

52

52

Fierce Healthcare

FEBRUARY 3, 2022

Meditation app Calm buys Ripple Health Group to build out mental healthcare offerings. rtorrence. Thu, 02/03/2022 - 15:04.

135

135

Outsourcing Pharma

FEBRUARY 17, 2022

In its forward-looking report on digital health, the consulting outfit offers predictions on what changes are ahead and how they might impact the field.

112

112

Roots Analysis

FEBRUARY 28, 2022

Over the past few years, the pharmaceutical industry is growing a tremendous pace. Considering patient’s health and safety, the drug products are expected to be free from microbial contamination and should be safe for use throughout the drug’s life cycle. Therefore, several quality checks are performed to ensure product’s sterility and stability. One of the stages that require quality assurance is packaging of the drug product, as compromised packaging could have serious consequences.

Packaging 52

Packaging Immunization 52

Pharma Marketing Network

FEBRUARY 25, 2022

“ Being more focused, more narrow in terms of the meeting objectives, making sure the right people are there, and making sure that you have quick hit type of interventions during the course of the week to keep track of status is serving us very well. I would suggest that even if and when things return to normal, a lot of those practices and a lot of those mindsets of ways of working will probably continue even after.” – Jeff Fayer, Novartis.

Communication 52

Communication 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Mirror

FEBRUARY 24, 2022

Taking care of your mental health can be affordable. All you will have to do is choose therapy options that fit in your budget. In this article, we have outlined the most affordable therapy options. While the options fall in the lower price range, they are all capable of delivering your expected results. The post Ways to Access Affordable Mental Health Services appeared first on Pharma Mirror Magazine.

52

52

pharmaphorum

FEBRUARY 21, 2022

Bayer has claimed EU approval for Kerendia, its new drug for chronic kidney disease (CKD) in people with type 2 diabetes, as the company tries to build a role of the drug alongside rival therapies from AstraZeneca and Johnson & Johnson. The approval is based on the phase 3 FIDELIO-DKD trial, in which Kerendia (finerenone) reduced the risk of kidney disease progression or renal death by 18% when added to the highest tolerated dose of standard therapy.

FDA 121

FDA 121

Fierce Healthcare

FEBRUARY 2, 2022

HHS: Disparities in video telehealth use highlight key barriers to access. rking. Wed, 02/02/2022 - 13:45.

144

144

Outsourcing Pharma

FEBRUARY 1, 2022

On World Cancer Day, the Union for International Cancer Control is launching a three-year campaign with the goal to improve cancer care around the globe.

108

108

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Roots Analysis

FEBRUARY 24, 2022

Since the approval of the first antisense therapy in 1998, oligonucleotides have been in light for their capabilities as therapeutic agents. Oligonucleotides are short synthetic nucleotide chains with immense potential in the diagnosis and treatment of a myriad of disease indications. In addition to therapeutics, these complex molecules act as a significant resource in various research applications.

52

52

Pharma Marketing Network

FEBRUARY 18, 2022

Join PMN and industry experts from Novo Nordisk, Esai, GSK, Otsuka and more for part 1 of a 2 part series on engagement. The PMN HCP Engagement Summit , 03/02/2022 @ 12PM EST, will focus on HCP Engagement on the following panel topics: Modular Content: Making It Work. Get insights for pharma marketing insiders on restructuring you content strategy allowing more flexibility and agility to deliver more relative content to your customers.

52

52

Pharma Mirror

FEBRUARY 25, 2022

Cambridge, UK, Framingham, MA (USA), and Dijon, France, Abzena, a partner research organization for integrated services from discovery through to clinical and commercial manufacturing for biologics and bioconjugates, Alira Health, an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare, and Oncodesign (ALONC -FR0011766229), a biopharmaceutical company dedicated to precision medicine, announce today that, with the launch of DRIVE™-Biologics,

52

52

pharmaphorum

FEBRUARY 3, 2022

India’s Dr Reddy’s Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German developer Nimbus Health for an undisclosed sum. While the regulatory framework for cannabinoid products remains fragmented and hard to navigate around the world, Germany has emerged as an early-mover.

Compounding 117

Compounding Insurance 117

Fierce Healthcare

FEBRUARY 1, 2022

Unvaccinated 23 times more likely than boosted to be hospitalized during omicron wave. dmuoio. Tue, 02/01/2022 - 16:13.

Hospitals 135

Hospitals 135

Outsourcing Pharma

FEBRUARY 7, 2022

The HIV-focused pharma company announced the agency has approved Cabenuva for administration as few as six times a year for adults living with the virus.

FDA 107

FDA 107

Roots Analysis

FEBRUARY 23, 2022

NGS has emerged as an evolutionary technology in modern biotechnology and healthcare research, enabling researchers to develop a better understanding of the cause and consequences of disease. Over the past few years, several companies have started offering a diverse range of genome sequencing products and services using various second and third generation sequencing technologies.

Immunization 52

Immunization 52

PharmD Live

FEBRUARY 17, 2022

By Richard Korecky, PharmD, BCGP. COVID-19 has profoundly changed the world we live in today and will continue to leave an indelible mark long after the pandemic has ended. One area of concern for both health care providers and their patients is the long-term effect of COVID-19 infection on patients with chronic diseases. Acute cardiac injury has been a well-documented feature of infection with SARS-CoV-2, which causes COVID-19 among patients requiring hospitalization.

Hospitals 52

Hospitals Documentation Labelling 52

Pharma Mirror

FEBRUARY 19, 2022

HONG KONG, Global pandemic control is still facing enormous challenges after more than two years since the outbreak of the COVID-19. Following the Delta and Beta variants, Omicron variant emerged at the end of 2021, and its enhanced infectivity has cast a shadow over the global COVID-19 control. Recently, Omicron quickly spread in Japan and South Korea, and the number of newly confirmed cases in South Korea has exceeded 90,000 for two consecutive days.

Vaccines 52

Vaccines 52

pharmaphorum

FEBRUARY 22, 2022

A study has suggested people with epilepsy may show patterns of activity and behaviour on social media that could serve as an early warning signal for sudden death – a rare but much feared complication of the disease. The study was carried out in six individuals who suffered sudden unexpected death in epilepsy (SUDEP), with the researchers analysing hundreds of Facebook posts for each subject in the six months leading up to their death, with the consent of surviving family members.

112

112

Fierce Healthcare

FEBRUARY 1, 2022

Healthcare data breaches hit all-time high in 2021, impacting 45M people. hlandi. Tue, 02/01/2022 - 16:25.

141

141

Outsourcing Pharma

FEBRUARY 8, 2022

The latest in the Diversity in Oncology series, taking place February 9, will discuss ways academia and community collaboration can narrow representation gaps.

101

101

Roots Analysis

FEBRUARY 22, 2022

With the increasing global population, the incidence rates of several chronic disease indications, such as diabetes, anaphylaxis, rheumatoid arthritis and psoriasis, are on the rise. This has led to a rise in the demand for effective treatment options for patients suffering from these diseases. Further, in order to improve the quality of life in these patients, companies have developed novel devices capable of delivering a variety of formulations of different drugs / therapies, in an efficient a

Dosage 52

Dosage Immunization FDA 52

Pharmig

FEBRUARY 16, 2022

Everyone wants to know where they come from, and microbiologists are no different. But were we grown in a petri dish. The post The history of pharmaceutical microbiology appeared first on Pharmig.

52

52

Pharma Mirror

FEBRUARY 18, 2022

Dean Kavanagh, Managing Director of QED Environmental Systems Ltd in the UK, has been appointed Co-Chair of the Council of Gas Detection and Environmental Monitoring (CoGDEM) Industry Subgroup. Dean will chair the Sub-group with Rob White, Sales Director of DD Scientific, with both chairs taking up their appointments early in 2022. The CoGDEM Industry Subgroup is one of the most influential steering groups, with meetings scheduled three times a year.

52

52

pharmaphorum

FEBRUARY 21, 2022

The clinical research industry has long struggled with participant diversity. One study found that only 5% of Black or Asian United Kingdom residents had ever participated in a clinical trial. A study of FDA-approved vaccine trials from 2011-2020 showed that 78% of participants were white, even though only 60% of the U.S. population was. . And then came COVID-19.

Vaccines 110

Vaccines FDA Hospitals 110

Fierce Healthcare

FEBRUARY 3, 2022

From Amazon to New Balance, consumer brand execs bring 'outsider' perspective to healthcare. agliadkovskaya. Thu, 02/03/2022 - 15:26.

118

118

Outsourcing Pharma

FEBRUARY 9, 2022

The companyâs analysis of trials conducted around the world last year shows cancers took four of the top five positions, with COVID-19 in second place.

102

102

Roots Analysis

FEBRUARY 21, 2022

Since the introduction of a gene sequencing method by Frederick Sanger in 1977, the field of genomic data collection and analysis has evolved significantly. Advancement in DNA sequencing technologies have resulted in noteworthy developments in various healthcare-related research fields, such as diagnostics and personalized medicine. However, the conventional nucleotide library preparation process has several challenges, including requirement of huge amount of starting materials, inadequate throu

Immunization 52

Immunization 52

NICE

FEBRUARY 16, 2022

NICE is working in partnership with the Care Quality Commission, Health Research Authority and Medicines and Healthcare products Regulatory Agency to deliver a multi-agency advisory service (MAAS) for developers and adopters of data-driven technologies, such as artificial intelligence (AI). This innovative new cross-regulatory service will provide support on the regulation and evaluation of AI technologies in health and care.

52

52